Snap Laboratories L L C
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: Snap Laboratories L L C stock price vs LEGN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LEGN's multiple
Needs EPS (TTM), LEGN P/E.
Implied fair value · at Snap Laboratories L L C's multiple
Needs EPS (TTM) is negative, Snap Laboratories L L C P/E.
Engine logicSnap Laboratories L L Cvalued onLEGN’smultiple
Metric by metric
Where each company leads, and how wide the gap is.
Snapshot Sep 4, 4:00 PM ET
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Snap Laboratories L L C Latest annual filing · LEGN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 85% equity / 15% debt · EV / Revenue 3.68x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SNAP LABORATORIES L L C · implied price per share
Reporting currency could not be verified.
Legend Biotech Corp · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Snap Laboratories L L C · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Net debt / EBITDA
Leverage against operating earnings
—
0.64x
Cash and equivalents
Liquid reserves on the balance sheet
—
$901.90M
Total debt
Interest-bearing obligations outstanding
—
$711.40M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.